Application

17316185 · Heterocyclic Amide compounds having an RORvt inhibitory action

Filed 2021-05-10 · Granted · Patent 11851449 (2023-12-26) The official file ↗The patent and its PDF ↗ · Art unit 1629 · Examiner Savitha M Rao Easy · CPC C07F 7/0812 · TAKEDA PHARMACEUTICAL COMPANY LIMITED · Takeda

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

20.6 mo

to disposition 31.5 mo

Statutes raised

112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.